Expert consensus workshop report

作者：Xin Ye, Weijun Fan, Hui Wang, Junjie Wang, Zhongmin Wang, Shanzhi Gu, Weijian Feng, Yiping Zhuang, Baodong Liu, Xiaoguang Li, Yuliang Li, Chengli Li, Yueyong Xiao, Po Song Yang, Xia Yang, Wuwei Yang, Junhui Chen, Rong Zhang, Zhengyu Lin, Zhiqiang Meng, Kaiwen Hu, Chen Liu, Zhongmin Peng, Yue Han, Yong Jin, Guangyan Lei, Bo Zhai, Guanghui Huang · 发表于：Journal of Cancer Research and Therapeutics · 年份：2018 · DOI：10.4103/jcrt.jcrt_221_18 · 被引用次数：94 · 研究领域：Lung Cancer Diagnosis and Treatment、Lung Cancer Treatments and Mutations、Medical Imaging and Pathology Studies

Although surgical resection with curative intent is the main therapy for both primary and metastatic lung tumors, about 80% of lung cancers cannot be removed by surgery. Because most patients with unresectable lung cancer only receive limited benefits from traditional radiotherapy and chemotherapy, many novel local treatment modalities have emerged including local ablation therapy. The Minimally Invasive Treatment of Lung Cancer Branch, Professional Committee of Minimally Invasive Treatment of Cancer of the Chinese Anti-Cancer Association and Committee on Tumor Ablations, Chinese College of Interventionalists have organized multidisciplinary experts to develop guidelines for this treatment modality. These guidelines aim at standardizing thermal ablation procedures, describing the indications for candidates, assessing outcomes, and preventing postablation complications.